Vanta Bioscience Ltd

BSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Vanta Bioscience Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
37.84% Fall from 52W High
-31.5
TTM PE Ratio
Price to Book Ratio
Below industry Median
2.1
Dividend yield 1yr %
0
TTM PEG Ratio
RSI
RSI is mid-range
42.6
MFI
MFI is mid-range
48.7

Vanta Bioscience Ltd shareholding Pattern

Promoter
69.4%
Public
30.6%
Promoter
69.4%
Public
30.6%
Promoter
69.4%
Public
30.6%
Promoter
69.4%
Public
30.6%
Promoter
69%
Public
31%
Promoter
69%
Public
31%

Vanta Bioscience Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
14
5Day EMA
67.30
10Day EMA
67.90
12Day EMA
68.00
20Day EMA
68.60
26Day EMA
68.80
50Day EMA
67.30
100Day EMA
65.10
200Day EMA
71.10
5Day SMA
69.70
10Day SMA
68.00
20Day SMA
66.70
30Day SMA
72.40
50Day SMA
69.40
100Day SMA
58.90
150Day SMA
59.70
200Day SMA
64.40
Delivery & Volume
Resistance & Support
63.18
Pivot
Resistance
First Resistance
63.18
Second Resistance
63.18
Third Resistance
63.18
Support
First Support
63.18
Second support
63.18
Third Support
63.18
Relative Strength Index
42.64
Money Flow Index
48.68
MACD
-0.79
MACD Signal
-0.83
Average True Range
3.52
Average Directional Index
20.21
Rate of Change (21)
-9.74
Rate of Change (125)
-16.87
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Family Care Hospitals Ltd.
-
-
-
Bandaram Pharma Packtech Ltd.
-
-
-
Transgene Biotek Ltd.
-
-
-
Medinova Diagnostic Services Ltd.
-
-
-
Choksi Laboratories Ltd.
-
-
-
Vanta Bioscience Ltd.
-
-
-
Deccan Health Care Ltd.
-
-
-

Vanta Bioscience Ltd Company background

Founded in: 2016
Managing director: Dopesh Raja Mulakala
Vanta Bioscience Limited was originally incorporated as a private limited company on 29th April 2016 with the name Vanta Bioscience Private Limited. The Company was converted into a public limited company and consequently, the name of the Company was changed to Vanta Bioscience Limited on 17th March 2017.The Promoters of the Company are Mohan Krishna Mulakala, Dopesh Raja Mulakala, Dr. Vyasmurti Madhavrao Shingatgeri, Dr. Soumya Simhadri, Shravan Chintapatla, Karishma Mulakala, Sajan Kiran Mulakala, Pradeep Chowdary and Dr. Chandrasekhar Rao Simhadri.Vanta Bioscience(VBS) is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries. In addition, it also provides risk assessment services for evaluatingthe safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. VBS also provides expert services for determination of health based exposure limits (e.g. permitted daily exposure (PDE) or allowable daily exposure (ADE) including occupational exposure limits (OEL) for pharmaceutical manufacturers.VBS entered into an asset transfer agreement dated February 18, 2016 with Kemin Industries South Asia Private Limited, Chennai for the purchase of fully operational toxicology facility Vanta Bioscience situated at Plot K2B, SIPCOT Industrial Estate, Gummidipundi, Chennai. The Company has taken possession of the said preclinical CRO facility at Gummidipundi, Chennai and has commenced commercial operations thereat from April 1, 2017. Currently the company is mainly doing previous pending research work and are also getting new work from existing clients of Vanta Bioscience erstwhile division of Kemin Industries South Asia Private Limited. One of the major services of VBS is conducting variety of in vitro (cell, tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world. Toxicology is a branch of biology, chemistry, and pharmacology concerned with the study of the adverse effects of chemicals on living organisms. It also studies the harmful effects of chemical, biological and physical agents in biological systems that establish the extent of damage in living organisms.VBS has state of the art facilities and infrastructure necessary for conduct of all kind of toxicology studies for Chemicals, Pharmaceuticals, Cosmetics, Agrochemicals like Pesticides, Insecticides, Excipients, Novel Feed Additives. The data generated from these studies are submitted to regulatory agencies worldwide before they are put in use for the consumption of domestic animals and human being. In addition, VBS also conducts preclinical proofofconcept (PoC) studies for novel pharmaceuticals and products intended for new indications in variety of animal models of human diseases through a robust process of validation.
Read More

Vanta Bioscience Ltd FAQs

You can easily buy Vanta Bioscience Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage